Induced pluripotent stem cell (iPSC) line MLi005-A derived from a patient with dominant dystrophic epidermolysis bullosa (DDEB)

Stem Cell Res. 2024 Mar:75:103306. doi: 10.1016/j.scr.2024.103306. Epub 2024 Jan 13.

Abstract

We have generated MLi005-A, a new induced pluripotent stem cell (iPSC) line derived from skin fibroblasts of a male patient with dominant dystrophic epidermolysis bullosa (DDEB). This iPSC line may be used as a model system for studies on skin integrity, the extracellular matrix and skin barrier function. The characterization of the MLi005-A cell line consisted of molecular karyotyping, next-generation sequencing of the COL7A1 alleles, pluripotency and differentiation potentials testing by immunofluorescence of associated markers in vitro. The MLi-005A line has been also tested for ability to differentiate into fibroblasts and keratinocytes and markers associated with these cell types.

Keywords: Collagen VII; Dominant dystrophic EB; Fibroblast; Keratinocyte; Pluripotency; iPSC line.

MeSH terms

  • Collagen Type VII / genetics
  • Collagen Type VII / metabolism
  • Epidermolysis Bullosa Dystrophica* / genetics
  • Epidermolysis Bullosa Dystrophica* / metabolism
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Keratinocytes / metabolism
  • Male
  • Skin / metabolism

Substances

  • Collagen Type VII
  • COL7A1 protein, human